RNAZ

TransCode Therapeutics, Inc. - Common Stock (RNAZ)

About TransCode Therapeutics, Inc. - Common Stock (RNAZ)

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.

Details

Daily high

$10.38

Daily low

$9.02

Price at open

$10.10

52 Week High

$776.16

52 Week Low

$6.15

Market cap

8.3M

Dividend yield

0.00%

Volume

35,543

Avg. volume

25,142

P/E ratio

-.01

TransCode Therapeutics, Inc. - Common Stock News